Skip to main content
. 2016 Feb 2;7(9):9742–9758. doi: 10.18632/oncotarget.7138

Figure 7. The schematic representation of anti-metastasis effects of zoledronate in human osteosarcoma U2OS cells.

Figure 7

Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cell-matrix and cell-cell interactions, migration potential, the invasive activity, and the adhesive ability by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.